[Simvastatin, an additional drug against breast cancer?]
- PMID: 36094232
- DOI: 10.1051/medsci/2022095
[Simvastatin, an additional drug against breast cancer?]
References
-
- Wahba HA, El-Hadaad HA. Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med 2015 ; 12 : 106–116.
-
- M-Rabet M, Bertucci F, Birnbaum D, Lopez M. Nectine-4 : un biomarqueur pronostique et une cible thérapeutique potentielle dans le cancer du sein triple-négatif. Med Sci (Paris) 2017 ; 33 : 936–9.
-
- Ansari L, Shiehzadeh F, Taherzadeh Z, et al. The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials. Cancer Gene Ther 2017 ; 24 : 189–193.
-
- Ahern TP, Lash TL, Damkier P, et al. Statins and breast cancer prognosis: evidence and opportunities. Lancet Oncol 2014 ; 15 : e461–e468.
-
- Yao H, He G, Yan S, et al. Triple-negative breast cancer: is there a treatment on the horizon?. Oncotarget 2017 ; 8 : 1913–1924.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical